HIV, cholesterol-lowering and cancer medicines dominate price disclosure reductions for April 2020 with almost thirty medicines across over 60 dosages and manners of administration taking an average cut of just over 20 per cent. …
Latest Video
New Stories
-
New national president for Hepatitis Australia
January 17, 2020 - - Latest News -
They would have already done it, if they could
January 17, 2020 - - Latest News -
New record for CSL as share prices tops $300
January 17, 2020 - - Latest News -
Leadership change coming for Novartis
January 16, 2020 - - Latest News -
Government moving to simplified non-legislated solution
January 16, 2020 - - Latest News -
Roche-Sarepta deal a positive sign for Australian access
January 16, 2020 - - Latest News -
PHARMAC wants more diabetes medicines, at the right price
January 16, 2020 - - Latest News